Concepedia

M. Pegram

MP

Statistics

Publications

6

Citations

723

H-Index

6

Active since

2000

Affiliations

University of California, Los Angeles(Current)

M. Pegram is an author at University of California, Los Angeles specializing in oncology, cancer therapeutics, and medicine.

Top concepts

Publications per year

2000–2005

6

Publications

6

Results of Two Open-Label, Multicenter Phase II Studies of Docetaxel, Platinum Salts, and Trastuzumab in HER2-Positive Advanced Breast Cancer

M. Pegram, Tadeusz Pieńkowski, Donald W. Northfelt et al. · JNCI Journal of the National Cancer Institute · 2004 · 271 citations · Full text

HER-2/neu Gene Amplification and Response to Paclitaxel in Patients With Metastatic Breast Cancer

G. Konecny, C. Thomssen, Hans‐Joachim Lück et al. · JNCI Journal of the National Cancer Institute · 2004 · 153 citations · Full text

Biological rationale for HER2/neu (c-erbB2) as a target for monoclonal antibody therapy.

M. Pegram, DJ Slamon · PubMed · 2000 · 149 citations

Phase II study of SU11248, a multitargeted receptor tyrosine kinase inhibitor (TKI), in patients (pts) with previously treated metastatic breast cancer (MBC)

Kathy D. Miller, HJ Burstein, Anthony Elias et al. · Journal of Clinical Oncology · 2005 · 75 citations

, , +6

Her-2/neu and urokinase-type plasminogen activator and its inhibitor in breast cancer.

Gottfried E. Konecny, M Untch, Jane Arboleda et al. · PubMed · 2001 · 65 citations

1–5 of 6